 Anemia, Sickle Cell
"Anemia, Sickle Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
| Descriptor ID |
D000755
|
| MeSH Number(s) |
C15.378.071.141.150.150 C15.378.420.155 C16.320.070.150 C16.320.365.155
|
| Concept/Terms |
Anemia, Sickle Cell- Anemia, Sickle Cell
- Anemias, Sickle Cell
- Sickle Cell Anemias
- Hemoglobin S Disease
- Disease, Hemoglobin S
- Hemoglobin S Diseases
- Sickle Cell Anemia
- Sickle Cell Disorders
- Cell Disorder, Sickle
- Cell Disorders, Sickle
- Sickle Cell Disorder
- Sickling Disorder Due to Hemoglobin S
- HbS Disease
- Sickle Cell Disease
- Cell Disease, Sickle
- Cell Diseases, Sickle
- Sickle Cell Diseases
|
Below are MeSH descriptors whose meaning is more general than "Anemia, Sickle Cell".
- Diseases [C]
- Hemic and Lymphatic Diseases [C15]
- Hematologic Diseases [C15.378]
- Anemia [C15.378.071]
- Anemia, Hemolytic [C15.378.071.141]
- Anemia, Hemolytic, Congenital [C15.378.071.141.150]
- Anemia, Sickle Cell [C15.378.071.141.150.150]
- Hemoglobinopathies [C15.378.420]
- Anemia, Sickle Cell [C15.378.420.155]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Anemia, Hemolytic, Congenital [C16.320.070]
- Anemia, Sickle Cell [C16.320.070.150]
- Hemoglobinopathies [C16.320.365]
- Anemia, Sickle Cell [C16.320.365.155]
Below are MeSH descriptors whose meaning is more specific than "Anemia, Sickle Cell".
This graph shows the total number of publications written about "Anemia, Sickle Cell" by people in this website by year, and whether "Anemia, Sickle Cell" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 2 | 0 | 2 | | 2004 | 1 | 0 | 1 | | 2005 | 2 | 0 | 2 | | 2006 | 1 | 0 | 1 | | 2007 | 2 | 0 | 2 | | 2008 | 5 | 1 | 6 | | 2009 | 3 | 1 | 4 | | 2010 | 3 | 1 | 4 | | 2011 | 14 | 1 | 15 | | 2012 | 5 | 0 | 5 | | 2013 | 3 | 1 | 4 | | 2014 | 15 | 0 | 15 | | 2015 | 10 | 0 | 10 | | 2016 | 9 | 0 | 9 | | 2017 | 8 | 0 | 8 | | 2018 | 12 | 0 | 12 | | 2019 | 11 | 0 | 11 | | 2020 | 10 | 1 | 11 | | 2021 | 12 | 1 | 13 | | 2022 | 11 | 0 | 11 | | 2023 | 15 | 0 | 15 | | 2024 | 7 | 1 | 8 | | 2025 | 17 | 0 | 17 | | 2026 | 9 | 1 | 10 |
To return to the timeline, click here.
Below are the most recent publications written about "Anemia, Sickle Cell" by people in Profiles.
-
Lucero MJ, Nozik E, Hassell K, Irwin DC, Buehler PW, Ferguson SK. Extracellular Hemoglobin, Hypoxia, and Macrophage-Mediated Pulmonary Vascular Remodeling in Hemolytic Disease. Int J Mol Sci. 2026 Sep 14; 27(18).
-
Schlenz AM, Murdaugh D, Heitzer AM, Longoria JN, Santos-Modesitt W, Martin A, Cavazos J, Schatz J, Hoyt CR, King A, Lance EI, Hardy S, Treadwell M. Consensus Standards and Recommendations for Developmental and Cognitive Surveillance, Screening, and Evaluation in Sickle Cell Disease: Executive Summary From the National Alliance of Sickle Cell Centers Neurocognitive Workgroup. Pediatr Blood Cancer. 2026 Sep; 73(9):e70569.
-
Celello A, McKinney C. Duffy Antigen Status, Hydroxyurea Dosing, and Disease Severity in Children and Young Adults With Sickle Cell Disease. Pediatr Blood Cancer. 2026 Sep; 73(9):e70577.
-
Lu S, Setua S, Khan MA, Bansal A, O'Boyle Q, Cabrales P, Irwin DC, Buehler PW, Palmer AF. Hemopexin Purification From Human Cohn Fraction IV Paste and Its Biophysical Characterization and Functional Evaluation in Sickle Cell Disease Mice. Biotechnol Bioeng. 2026 Sep; 123(9):2229-2237.
-
Vallelian F, Schaer DJ, Lechartier B, Buehler PW, Irwin DC. Sickle cell disease-associated pulmonary hypertension: an integrated framework linking pathologies, mechanisms, and clinical phenotypes. EBioMedicine. 2026 Jun; 128:106288.
-
Lucero MJ, Setua S, Thangaraju K, Khan A, Lamb DR, Lisk C, Swindle D, Cendali FI, Dzieciatkowska M, Stephenson D, Pak DI, Tolson R, Zaeske S, Rana NK, Khan S, Westover N, Davizon-Castillo P, George G, Hassell K, Nuss R, D'Alessandro A, Manolova V, Irwin DC, Buehler PW. Ferroportin inhibition attenuates pulmonary hypertension in hypoxic sickle cell disease mice. Blood Adv. 2026 May 12; 10(9):3229-3242.
-
Strayer J, Wu X, Choe H, Iyer PR, Gómez-Pastora J, Moorman W, Cefaratti J, West A, Doon-Ralls J, Landes K, Della-Moretta S, Palmer AF, Zborowski M, Buehler PW, Chalmers JJ, Desai PC. Sickle cell vaso-occlusive episodes correlate with the magnetic heterogeneity of red blood cells. Blood Adv. 2026 Apr 28; 10(8):2836-2846.
-
Sridhar N, Song M, Stowell MHB, Hassell KL, Ding X. Acoustic probing of new biomarkers for rapid sickle cell disease screening. Lab Chip. 2026 03 31; 26(7):2187-2200.
-
Jenkins AM, Hendry E, Power-Hays A, Valentino M, Hall M, Kyler KE, Antoon JW, Tang Girdwood S, Goldman JL, Morel AN, Savage TJ, Orth LE, Archer NM. Increasing ketamine administration in children's hospitals for youth with sickle cell disease. Blood Adv. 2026 Feb 24; 10(4):1106-1113.
-
Jenkins AM, Hendry E, Power-Hays A, Valentino M, Hall M, Kyler KE, Antoon JW, Tang Girdwood S, Goldman JL, Morel AN, Savage TJ, Orth LE, Archer NM. Increasing ketamine administration in children's hospitals for youth with sickle cell disease. Blood Adv. 2026 Feb 24; 10(4):1106-1113.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|